Article

Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral Sclerosis

2024-04-25

Abstract excerpt

<title>Abstract</title> <p>Amyotrophic Lateral Sclerosis (ALS) is a devastating, immensely complex neurodegenerative disease by lack of effective treatments. To date, the challenge to establishing effective treatment for ALS remains formidable, partly due to inadequate translation of existing human genetic findings into actionable ALS-specific pathobiology for subsequent therapeutic development. We developed a ne...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 7c8e4d49-d0e2-5abf-a5c8-c93b20bab57e
DOI: 10.21203/rs.3.rs-4271755/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral SclerosisDOI 10.21203/rs.3.rs-4271755/v1Read

Network medicine informed multi-omics integration identifies drug targets and repurposable medicines for Amyotrophic Lateral SclerosisSemantic proximity Read

Harnessing Transcriptomic Signals for Amyotrophic Lateral Sclerosis to Identify Novel Drugs and Enhance Risk PredictionSemantic proximity Read

Harnessing transcriptomic signals for amyotrophic lateral sclerosis to identify novel drugs and enhance risk predictionSemantic proximity Read

A network-based systems genetics framework identifies pathobiology and drug repurposing in Parkinson’s diseaseSemantic proximity Read

5-Repurposed Drug Candidates Identified in Motor Neurons and Muscle Tissues with Amyotrophic Lateral Sclerosis by Network Biology and Machine Learning Based on Gene ExpressionSemantic proximity Read

omicSynth: an Open Multi-omic Community Resource for Identifying Druggable Targets across Neurodegenerative DiseasesSemantic proximity Read

A 5-repurposed drug candidates identified in motor neurons and muscle tissues with amyotrophic lateral sclerosis by network biology and machine learning based on gene expressionSemantic proximity Read

Prioritization of therapeutic targets for amyotrophic lateral sclerosis using protein-wide Mendelian randomization analysisSemantic proximity Read

Constructing Parkinson's disease progression- endotype molecular networks for drug repurposing: multi-omics evidence aggregation and large-scale real-world data validationSemantic proximity Read

TBK1, a prioritized drug repurposing target for amyotrophic lateral sclerosis: evidence from druggable genome Mendelian randomization and pharmacological verification in vitroSemantic proximity Read

Multi-omic machine learning overcomes transcriptomic blind spots to rescue therapeutic targets in ALSSemantic proximity Read

Multicomponent Mendelian randomization and machine learning studies of potential drug targets for neurodegenerative diseasesSemantic proximity Read